Fever of unknown origin resident survival guide: Difference between revisions

Jump to navigation Jump to search
Gerald Chi (talk | contribs)
mNo edit summary
Gerald Chi (talk | contribs)
mNo edit summary
Line 50: Line 50:
* '''Infections'''<ref>{{Cite journal| issn = 1058-4838| volume = 24| issue = 3| pages = 291–300; quiz 301-302| last = Hirschmann| first = J. V.| title = Fever of unknown origin in adults| journal = Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America| date = 1997-03| pmid = 9114175}}</ref>
* '''Infections'''<ref>{{Cite journal| issn = 1058-4838| volume = 24| issue = 3| pages = 291–300; quiz 301-302| last = Hirschmann| first = J. V.| title = Fever of unknown origin in adults| journal = Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America| date = 1997-03| pmid = 9114175}}</ref>
: ''Localized''
: ''Localized''
: – Endocarditis
: – [[Endocarditis]]
: – Intraabdominal infections
: – [[Intra-abdominal infection]]s
: – Urinary tract infections
: – [[Urinary tract infection]]s
: – Osteomyelitis
: – [[Osteomyelitis]]
: – Upper respiratory tract infections
: – [[Upper respiratory tract infection]]s
: – Infected peripheral vessels
: – [[Phlebitis|Infected peripheral vessels]]
: ''Generalized''
: ''Generalized''
: – Bacterial
: – [[Bacteria|Bacterial]]
: – Mycobacterial
: – [[Mycobacteria|Mycobacterial]]
: – Fungal
: – [[Fungus|Fungal]]
: – Viral
: – [[Virus|Viral]]
: – Parasitic
: – [[Parasite|Parasitic]]
* '''Neoplasia'''
* '''Neoplasia'''
: – Lymphoproliferative disorders
: – [[Lymphoproliferative disorder]]s
: – Leukemia
: – [[Leukemia]]
: – Myelodysplastic diseases
: – [[Myelodysplastic syndrome]]
: – Solid tumors
: – [[Cancer|Solid tumors]]
* '''Rheumatologic disorders'''
* '''Rheumatologic disorders'''
: – Adult Still's disease
: – [[Adult onset Still's disease]]
: – Giant cell arteritis
: – [[Giant cell arteritis]]
: – Polymyalgia rheumatica
: – [[Polymyalgia rheumatica]]
: – Other forms of vasculitis (e.g., polyarteritis nodosa, Wegener's granulomatosis, Takayasu's arteritis)
: – [[vasculitis|Other forms of vasculitis]] (e.g., [[polyarteritis nodosa]], [[Wegener's granulomatosis]], [[Takayasu's arteritis]])
: – Other rheumatologic disorders (e.g., systemic lupus erythematosus, rheumatoid arthritis, Sjogren's disease)
: – [[rheumatism|Other rheumatologic disorders]] (e.g., [[systemic lupus erythematosus]], [[rheumatoid arthritis]], [[Sjogren's syndrome]])
* '''Miscellaneous'''
* '''Miscellaneous'''
: – Granulomatous disorders
: – [[Granuloma|Granulomatous disorders]]
: – Alcoholic hepatitis
: – [[Hepatitis]]
: – Vascular disorders (e.g., pulmonary embolism, hematoma)
: – [[Vessel|Vascular disorders]] (e.g., [[pulmonary embolism]], [[hematoma]])
: – Drug fever
: – [[Drug fever]]
* '''Hereditary''' (e.g., familial Mediterranean fever)
* '''Hereditary''' (e.g., [[familial Mediterranean fever]])
* '''Endocrine'''
* '''Endocrine'''
: – Hyperthyroidism
: – [[Hyperthyroidism]]
: – Thyroiditis
: – [[Thyroiditis]]
: – Adrenocortical insufficiency
: – [[Adrenocortical insufficiency]]
* '''Factitious fever'''
* '''Factitious fever'''



Revision as of 20:33, 18 March 2015

Fever of unknown origin
Resident Survival Guide
Diagnostic Criteria
Classification
Causes
Focused Initial Rapid Evaluation
Empiric Therapy
Dos
Don'ts

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Synonyms and keywords: febris continua e causa ignota; febris e causa ignota; febris E.C.I.; FUO; PUO; pyrexia of unknown origin

Diagnostic Criteria

In 1961, Petersdorf and Beeson suggested the following criteria:[1][2]

  • Fever higher than 38.3°C (100.9°F) on several occasions
  • Persisting without diagnosis for at least 3 weeks
  • At least 1 week's investigation in hospital

Classification

In 1991, Durack and Street proposed a revised definition in which cases of FUO are categorized into four subclasses: classic FUO, nosocomial (health care-associated) FUO, neutropenic (immune-deficient) FUO, and HIV-related FUO.[3]

Classic FUO

Fever (>38.3° C or >100.9° F) for >3 weeks with no identified cause after 3 days of hospital evaluation or ≥3 outpatient visits

Nosocomial (health care-associated) FUO

Fever (>38.3° C or >100.9° F) in hospitalized patients receiving acute care and with no infection present or incubating on admission if the diagnosis remains uncertain after 3 days of appropriate evaluation

Neutropenic (immune-deficient) FUO

Fever (>38.3° C or >100.9° F) in patients with immunodeficiencies if the diagnosis remains uncertain after 3 days of appropriate evaluation, including negative cultures after 48 hours

HIV-related FUO

Fever (>38.3° C or >100.9° F) for >3 weeks in outpatients with confirmed HIV infection or >3 days in inpatients with confirmed HIV infection if the diagnosis remains uncertain after appropriate evaluation

Causes

Localized
Endocarditis
Intra-abdominal infections
Urinary tract infections
Osteomyelitis
Upper respiratory tract infections
Infected peripheral vessels
Generalized
Bacterial
Mycobacterial
Fungal
Viral
Parasitic
  • Neoplasia
Lymphoproliferative disorders
Leukemia
Myelodysplastic syndrome
Solid tumors
  • Rheumatologic disorders
Adult onset Still's disease
Giant cell arteritis
Polymyalgia rheumatica
Other forms of vasculitis (e.g., polyarteritis nodosa, Wegener's granulomatosis, Takayasu's arteritis)
Other rheumatologic disorders (e.g., systemic lupus erythematosus, rheumatoid arthritis, Sjogren's syndrome)
  • Miscellaneous
Granulomatous disorders
Hepatitis
Vascular disorders (e.g., pulmonary embolism, hematoma)
Drug fever
Hyperthyroidism
Thyroiditis
Adrenocortical insufficiency
  • Factitious fever

FIRE: Focused Initial Rapid Evaluation

Focused Initial Rapid Evaluation (FIRE) should be undertaken to identify patients requiring urgent intervention.

Abbreviations: CBC, complete blood count; CI, cardiac index; CK-MB, creatine kinase MB isoform; CVP, central venous pressure; DC, differential count; ICU, intensive care unit; INR, international normalized ratio; LFT, liver function test; MAP, mean arterial pressure; PCWP, pulmonary capillary wedge pressure; PT, prothrombin time; PTT, partial prothrombin time; SaO2, arterial oxygen saturation; SBP, systolic blood pressure; ScvO2, central venous oxygen saturation; SvO2, mixed venous oxygen saturation; SMA-7, sequential multiple analysis-7.

Suspected FUO


 
 

Empiric Antibiotic Therapy

Dos

Don'ts

References

  1. Mandell's Principles and Practices of Infection Diseases 6th Edition (2004) by Gerald L. Mandell MD, MACP, John E. Bennett MD, Raphael Dolin MD, ISBN 0-443-06643-4 · Hardback · 4016 Pages Churchill Livingstone
  2. Harrison's Principles of Internal Medicine 16th Edition, The McGraw-Hill Companies, ISBN 0-07-140235-7
  3. Durack, D. T.; Street, A. C. (1991). "Fever of unknown origin--reexamined and redefined". Current Clinical Topics in Infectious Diseases. 11: 35–51. ISSN 0195-3842. PMID 1651090.
  4. Hirschmann, J. V. (1997-03). "Fever of unknown origin in adults". Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. 24 (3): 291–300, quiz 301-302. ISSN 1058-4838. PMID 9114175. Check date values in: |date= (help)